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Inappropriate sinus tachycardia (IST) is a rare disorder
deﬁned as a nonparoxysmal rhythm originating from the
sinus node associated with palpitations with a resting heart
rate 4100 beats/min and a 24-hour mean heart rate 490
beats/min, with all other potential causes of sinus tachycardia
excluded.1 Patients with IST may experience debilitating
palpitations, lightheadedness, chest discomfort, poor exer-
cise tolerance, and other multisystem complaints.2 It has a
complex pathogenesis with many proposed mechanisms,
including increased resting sympathetic tone,3 decreased
parasympathetic response,1,3 and increased intrinsic sinus
node rate.3
Treatment of IST is variably successful in reducing
symptoms. If β-blockers and calcium channel blockers are
ineffective, ivabradine, an inhibitor of the hyperpolarizing
sodium current, may be better tolerated.4 For medically
refractory symptoms, several methods of endocardial and
epicardial ablation to modify the sinus node have been
developed.5–6 Long-term follow-up is unknown for many of
these techniques. We report 2 patients with complex cases of
IST and debilitating symptoms despite medical therapy and
previous invasive interventions. Both patients were success-
fully treated with epicardial radiofrequency ablation facili-
tated by minimally invasive video-assisted thoracoscopic
surgery (VATS), with no recurrence of sinus tachycardia
after up to 4 years of follow-up.KEYWORDS Epicardial; Inappropriate sinus tachycardia; Minimally invasive
surgery; Pacing; Radiofrequency ablation; Sinus node modiﬁcation; Video-
assisted thoracoscopic surgery
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Case 1
Background
A 22-year-old female patient presented to our institution with
persistent symptoms of palpitations, exercise intolerance, and
dizziness. She had a complex 5-year history beginning with
dual-chamber pacemaker implantation for suspected viral-
mediated complete atrioventricular (AV) block. She was
subsequently diagnosed with IST after her intrinsic AV
conduction recovered. Extracardiac causes of sinus tachycardia
were excluded with laboratory evaluations, and her echocardio-
gram was normal with an ejection fraction of 60%. Her
symptoms persisted despite medication trials (β-blockers,
diltiazem, and clonidine), His bundle ablation, and upgrade to
biventricular pacing to treat pacing-related dyssynchrony with
multiple attempts at pacemaker reprogramming to optimize its
settings. Previous electrophysiology studies demonstrated ante-
grade AV conduction with a cycle length of 660 ms with no
retrograde conduction and no inducible atrial, AV nodal, or
ventricular arrhythmias. Subsequent endocardial IST ablation
attempts were aborted because of unacceptable diaphragmatic
stimulation. Superior vena cava (SVC) stenosis developed and
persisted despite venoplasty, limiting further intravenous inter-
ventions. She continued to have debilitating symptoms during
tachycardia, and pacemaker interrogation demonstrated sinus
rhythm with 100% biventricular pacing; histograms demon-
strated rates 70–140 beats/min, with 10% of heart rates above
100 beats/min. Because of the previous difﬁculties during
endocardial ablation, bilateral VATS with epicardial sinus node
modiﬁcation was performed. In addition, to eliminate the
gradient in the SVC, an epicardial pacing systemwas implanted
so that the endocardial leads could be extracted as a staged
procedure, as previously described.7
Procedure
The patient underwent general anesthesia with double-lumen
endotracheal intubation. She was in sinus rhythm with apen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.08.001
Figure 2 Mapping the right atrium at the junction of the superior vena
cava, sulcus terminalis (black arrow), and right atrial appendage (RAA),
with visualization of the phrenic nerve (white arrow). The pericardium is
labeled with an asterisk.
KEY TEACHING POINTS
 Sinus node modiﬁcation may allow relief of
symptoms in patients with medically refractory
inappropriate sinus tachycardia.
 Epicardial sinus node modiﬁcation is a potentially
successful treatment of inappropriate sinus
tachycardia when endocardial sinus node
modiﬁcation is unsuccessful or cannot be
performed because of limited vascular access or
phrenic nerve proximity.
 Video-assisted thoracoscopic surgery has
advantages in comparison with other endocardial
and epicardial ablation techniques, which include
avoiding complications such as phrenic nerve
injury and superior vena cava stenosis, addressing
complexities encountered in patients with multiple
previous procedures, and achieving long-lasting
freedom from tachycardia.
 Symptoms of inappropriate sinus tachycardia may
recur despite successful elimination of tachycardia;
therefore, ablative therapies remain a last resort
after conservative medical therapy has failed.
Heart Rhythm Case Reports, Vol 1, No 6, November 2015478cycle length of 600–630 ms. The right lung was deﬂated, and
two 5-mm ports and a single 10-mm port were placed along
the anterior axilla bilaterally (Figure 1). With direct visual-
ization of the phrenic nerve, the pericardium was opened.
The sinus node was mapped with a bipolar AtriCure (West
Chester, OH) linear pen (Figure 2). The sinus node activation
occurred 25–30 ms before the onset of the P wave. Ablation
using the Coolrail system (AtriCure) was performed with a
maximum power of 50 W until the impedance dropped. The
earliest activation moved inferiorly down the sulcus termi-
nalis, and ablation was continued cranial to caudal to the
junction with the inferior vena cava. After completion of the
epicardial ablation, a subdiaphragmatic incision was made,Figure 1 Video-assisted thoracoscopic surgery for sinus node modiﬁca-
tion in patient 1, with placement of ports in the right thorax.and right atrial (Model 4965, Medtronic, Minneapolis, MN)
and right ventricular (Model 5071, Medtronic, Minneapolis,
MN) leads were placed under transesophageal echocardio-
graphic guidance. The left thorax was also entered for direct
epicardial placement of a left ventricular lead (Medtronic
model 5071). The leads were then tunneled subcutaneously
to the pocket in the left chest and connected to the pace-
maker. At the conclusion of the procedure, the patient had a
stable ectopic atrial rhythm with a superior P-wave axis and a
cycle length of 790–820 ms. She experienced asymptomatic
right hemidiaphragm elevation, which resolved within 48
hours. All sinus rate–lowering medications were discontin-
ued. The endocardial leads were removed 3 months later
after the conﬁrmation of stable epicardial pacing. After 4
years of follow-up, she remains free of sinus tachycardia.
Intermittent palpitations have been correlated to sympto-
matic premature ventricular beats that are now suppressed
with ﬂecainide. On cardiopulmonary testing, her exercise
tolerance is improved but limited by the rate response of her
pacemaker. Device interrogation conﬁrms 100% atrial-
biventricular sequential pacing with appropriate sensor-
driven histograms.Case 2
Background
A 36-year-old female patient presented to our institution for
persistent symptoms of fatigue, reduced exercise tolerance,
and intermittent palpitations over 8 years. Although serial
Holter monitoring demonstrated sinus tachycardia and no
other clinical arrhythmias, she had undergone at other
institutions cavotricuspid isthmus ablation and pulmonary
vein isolation for nonsustained atrial ﬂutter and atrial
ﬁbrillation inducible with aggressive atrial stimulation and
AV node slow pathway modiﬁcation for dual AV node
physiology with single echo beats. Her symptoms persisted,
and an implantable loop recorder demonstrated recurrent
sinus tachycardia with heart rates exceeding 120 beats/min at
rest. Endocardial sinus node modiﬁcation was transiently
successful in reducing the patient’s resting heart rate, but it
479Schleifer et al VATS Epicardial Sinus Node Modiﬁcationlater increased to 90 beats/min, and her symptoms recurred
despite trials of metoprolol, diltiazem, propafenone, sotalol,
and ivabradine. Repeat Holter monitoring with metoprolol
and ivabradine showed an average rate of 98 beats/min
(range 76–141 beats/min). An electrophysiology study was
repeated, and the earliest activation was mapped to the base
of the right atrial appendage and SVC-right atrial junction,
although there were no endocardial activations that preceded
the P-wave onset. The sinus rate remained 90–100 beats/min
throughout the procedure despite 34 radiofrequency appli-
cations in this location, and epicardial ablation by VATS was
recommended.
Procedure
The patient underwent general anesthesia with double-lumen
endotracheal intubation. Three ports were placed along the
right axilla for thoracic access. With direct visualization of
the phrenic nerve, the pericardium was opened. Mapping
performed at the SVC-right atrial junction identiﬁed the
earliest activation 165 ms before the onset of the P wave
during isoproterenol infusion. Radiofrequency ablation was
performed with the AtriCure linear pen at the site of earliest
activation with a maximum power of 50 W. The site of
earliest activation migrated laterally and inferiorly along the
sulcus terminalis. An ectopic atrial rhythm at the base of the
right atrial appendage was also ablated. Transmural lesions
were conﬁrmed by documenting the absence of local electro-
grams at each location ablated. The patient’s resting heart
rate decreased from 110 beats/min at the beginning of the
procedure to 84 beats/min, now originating from an ectopic
atrial focus. Her ivabradine was discontinued, but she
remained on a reduced dose of β-blockers. On follow-up,
Holter monitoring demonstrated an average heart rate of
86 beats/min (range 74–105 beats/min). She remains asymp-
tomatic after 3 years of follow-up, and her exercise capacity
as measured by cardiopulmonary exercise testing has more
than doubled.
Discussion
Our cases show that long-term success in treating IST is
possible by sinus node modiﬁcation via an epicardial
approach with VATS. Endocardial approaches to sinus node
modiﬁcation risk phrenic nerve palsy and SVC stenosis.
These structures can be protected and the atrial anatomy and
phrenic nerve directly visualized in a VATS approach. The
VATS approach also facilitates epicardial pacing lead place-
ment, which was required in the ﬁrst case.10 Long-term
follow-up in both patients demonstrated no recurrence of
sinus tachycardia or occurrence of other atrial arrhythmias.
Medical therapy for IST frequently does not completely
relieve symptoms. A randomized crossover trial of 20
patients demonstrated persistent IST symptoms in 30% of
patients on ivabradine compared with 55% of patients on
metoprolol.4 Symptoms also frequently recur after endocar-
dial sinus node modiﬁcation. Lee et al7 reported 12 patients
who underwent endocardial sinus node modiﬁcation guidedby intracardiac echocardiography; 2 patients had recurrent
IST, and 4 others had recurrent palpitations. Man et al5
reported 29 patients who underwent endocardial radiofre-
quency ablation and 34% had recurrent symptoms. Mar-
rouche et al6 reported a 44% recurrence of symptoms after 39
patients with IST underwent sinus node modiﬁcation guided
by nonﬂuoroscopic electroanatomic mapping and 28%
required a second procedure.
Epicardial ablation may be necessary when endocardial
ablation cannot be performed, such as patients with limited
vascular access like patient 1, or when previous endocardial
ablation attempts have failed, as in patient 2. Epicardial sinus
node modiﬁcation would theoretically be more effective than
endocardial ablation because the sinus node is an epicardial
structure. Multiple epicardial approaches to IST have been
attempted. The VATS approach was described by Beaver
et al8 in a patient in whom endocardial ablation could not be
performed because of proximity to the phrenic nerve. The
procedure succeeded without complication and no recur-
rence after 1-month follow-up. Our observations conﬁrm that
this approach can produce long-lasting freedom from tachy-
cardia. The largest series of patients undergoing an epicardial
approach is a series of 5 cases performed via percutaneous
epicardial access without direct visualization, with a mean
follow-up of 30 months.9 While VATS is a more complex
procedure requiring single lung ventilation and thoraco-
scopy, direct visualization of the phrenic nerve and atrial
structures (Figure 2) may reduce the risk of permanent
complications compared with other epicardial approaches.
Further studies directly comparing VATS and percutaneous
epicardial approaches are required to determine the optimum
approach to sinus node modiﬁcation.
Because of the invasive nature of the procedure and the
potential for recurrent symptoms despite reduction in atrial
rate, ablation for IST is a last resort for debilitating,
medically refractory symptoms.1 Both our patients had
undergone lengthy trials of multiple medications, with
volume expansion, exercise training, and other conservative
measures exhausted. Attempts at endocardial sinus node
modiﬁcation had either already failed or was not possible
because of limited vascular access or phrenic nerve prox-
imity. These cases show that epicardial sinus node modiﬁ-
cation via VATS can effectively eliminate tachycardia and
tachycardia-related symptoms. Both our patients have had no
recurrence of sinus tachycardia and no symptoms related to
atrial arrhythmias after 3–4 years of follow-up.Conclusion
IST is a rare disorder associated with debilitating symptoms
that may persist despite pharmacotherapy and endocardial
radiofrequency ablation. We present 2 patients with symp-
toms refractory to multiple interventions who were success-
fully treated by epicardial sinus node modiﬁcation via
VATS. The advantages of minimally invasive techniques
include addressing complexities encountered in patients with
Heart Rhythm Case Reports, Vol 1, No 6, November 2015480multiple previous procedures, avoiding complications, and
achieving long-lasting freedom from tachycardia.References
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